drugset / Trial / NCT01789281
Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.
NaSingle-groupOpen-labelTreatment
Summary
Study to allow access to everolimus for patients who are on everolimus treatment in a Novartis-sponsored study and are benefiting from the treatment as judged by the investigator
Timeline
- Start
- 2013-05-14
- Primary completion
- 2020-08-28
- Completion
- 2020-08-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Everolimus | Small molecule | — | Oral |
| Background | Octreotide | Peptide | — | Intramuscular |